Evidence 1
Activity
Activity
67% Hemolysis
Toxicity
50 µM
Hemolytic
Cytotoxic
67% Hemolysis | 50 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
A convenient solid-phase strategy for the synthesis of antimicrobial cyclic lipopeptides. | Org Biomol Chem | 2013